| Online-Ressource |
Verfasst von: | Froelich, Matthias F. [VerfasserIn]  |
| Capoluongo, Ettore [VerfasserIn]  |
| Kovacs, Zsolt [VerfasserIn]  |
| Patton, Simon J. [VerfasserIn]  |
| Lianidou, Evi S. [VerfasserIn]  |
| Haselmann, Verena [VerfasserIn]  |
Titel: | The value proposition of integrative diagnostics for (early) detection of cancer |
Titelzusatz: | on behalf of the EFLM interdisciplinary Task and Finish Group “CNAPS/CTC for early detection of cancer” : EFLM paper |
Verf.angabe: | Matthias F. Froelich, Ettore Capoluongo, Zsolt Kovacs, Simon J. Patton, Evi S. Lianidou, and Verena Haselmann, on behalf of the EFLM interdisciplinary Task and Finish Group “CNAPS/CTC for early detection of cancer” |
E-Jahr: | 2022 |
Jahr: | February 24, 2022 |
Umfang: | 9 S. |
Fussnoten: | Gesehen am 20.02.2024 |
Titel Quelle: | Enthalten in: Clinical chemistry and laboratory medicine |
Ort Quelle: | Berlin [u.a.] : De Gruyter, 1998 |
Jahr Quelle: | 2022 |
Band/Heft Quelle: | 60(2022), 6, Seite 821-829 |
ISSN Quelle: | 1437-4331 |
Abstract: | Disruptive imaging and laboratory technologies can improve clinical decision processes and outcomes in oncology. However, certain obstacles must be overcome before these technologies can be fully implemented as part of the standard for care. An integrative diagnostic approach represents a unique opportunity to unleash the full diagnostic potential and paves the way towards personalized cancer diagnostics. To meet this demand, an interdisciplinary Task Force of the EFLM was initiated as a consequence of an EFLM/ESR during the CELME 2019 meeting in order to evaluate the clinical value of CNAPS/CTC (circulating nucleic acids in plasma and serum/circulating tumor cells) in early detection of cancer. Here, an overview of current disruptive techniques, their clinical implications and potential value of an integrative diagnostic approach is provided. Furthermore, requirements such as the establishment of diagnostic tumor boards, development of adequate software solutions and a change of mindset towards a new generation of diagnosticians providing actionable health information are presented. This development has the potential to elevate the position and clinical recognition of diagnosticians. |
DOI: | doi:10.1515/cclm-2022-0129 |
URL: | Bitte beachten Sie: Dies ist ein Bibliographieeintrag. Ein Volltextzugriff für Mitglieder der Universität besteht hier nur, falls für die entsprechende Zeitschrift/den entsprechenden Sammelband ein Abonnement besteht oder es sich um einen OpenAccess-Titel handelt.
kostenfrei: Volltext: https://doi.org/10.1515/cclm-2022-0129 |
| kostenfrei: Volltext: http://www.degruyter.com/document/doi/10.1515/cclm-2022-0129/html |
| DOI: https://doi.org/10.1515/cclm-2022-0129 |
Datenträger: | Online-Ressource |
Sprache: | eng |
Sach-SW: | cancer |
| circulating tumor cells (CTC) |
| colorectal cancer |
| ctDNA |
| integrative diagnostics |
| liquid biopsy |
K10plus-PPN: | 1881199878 |
Verknüpfungen: | → Zeitschrift |
¬The¬ value proposition of integrative diagnostics for (early) detection of cancer / Froelich, Matthias F. [VerfasserIn]; February 24, 2022 (Online-Ressource)